DR. LALITHA ANAND M.D. NPI 1285948380

NPI Information

  • NPI: 1285948380
  • Provider Name: DR. LALITHA ANAND, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 1 DIAMOND HILL RD
    BERKELEY HEIGHTS, NJ
    ZIP 07922
  • Phone: (908) 277-8890

Map and Directions

Get Directions

NPI Details

DR. Lalitha Anand, M.D. is a hematology and oncology internal medicine in Berkeley Heights, NJ with 17 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Lalitha Anand, M.D. NPI is 1285948380. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

1 DIAMOND HILL RD
BERKELEY HEIGHTS, NJ
ZIP 07922-104
Phone: (908) 277-8890
Fax: (908) 673-7389

The NPI 1285948380 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Protein measurement, serum (HCPCS:84165)
  • Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Coagulation function measurement, d-dimer; quantitative (HCPCS:85379)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Red blood count, manual test (HCPCS:85044)
  • Blood test, clotting time (HCPCS:85610)
  • Unclassified drugs (HCPCS:J3490)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Folic acid level, serum (HCPCS:82746)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Coagulation assessment blood test, plasma or whole blood (HCPCS:85730)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Total protein level, blood (HCPCS:84155)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)

The enumeration date for this NPI number is 7/30/2010 and was last updated on 10/2/2019.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology25MA10680500NEW JERSEYYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.